冠心病診斷影像設備市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Coronary Heart Disease Diagnostic Imaging Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月29日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球冠心病診斷影像設備市場佔有率達到18 億美元，在冠心病(CHD) 患病率不斷上升以及對早期診斷和診斷的需求不斷成長的推動下，2024 年至2032 年期間將呈現6.6 % 的成長率。隨著全球冠心病發病率上升，越來越需要先進的影像技術來早期檢測病情。早期診斷可以及時干預，降低嚴重後果的風險。對主動醫療保健的關注推動了對複雜診斷影像設備的需求，從而擴大了市場，因為醫療保健系統優先考慮有效的早期檢測解決方案。

整個冠心病診斷影像設備產業根據模式、應用、最終用途和地區進行細分。

由於其卓越的成像能力和精度，到 2032 年，電腦斷層掃描 (CT) 領域將累積 4.438 億美元的收入。 CT 掃描可提供心臟和血管的詳細橫斷面影像，從而能夠準確診斷冠狀動脈疾病並評估斑塊形成。該技術能夠快速產生高解析度影像，使其成為尋求可靠、高效診斷工具的臨床醫生的首選。隨著對詳細心臟影像的需求增加，CT 領域將主導市場。

由於緊急情況下對快速、準確診斷的迫切需求，心臟病發作領域在 2023 年收入達 5.857 億美元。及時識別心臟病發作對於有效治療和改善患者預後至關重要。 CT 和 MRI 等診斷影像設備在評估心臟損傷程度和指導介入措施方面發揮關鍵作用。隨著心臟病發病率持續上升，該領域對先進影像解決方案的需求將推動市場顯著成長。

由於其先進的醫療基礎設施、冠心病的高盛行率以及對醫療技術的大量投資，到2032年，美國冠心病診斷影像設備市場將達到13億美元。該國強大的醫療保健系統和尖端診斷工具（包括先進的成像技術）的高採用率推動了市場成長。此外，美國受益於持續的研發工作，使其成為冠心病診斷成像設備產業擴張和創新的關鍵貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 冠心病患病率增加
  - 診斷影像技術的進步
  - 提高對冠心病的認知和早期診斷
  - 對非侵入性診斷工具的需求不斷成長
- 產業陷阱與挑戰
  - 成像設備成本高
  - 缺乏熟練的專業人員
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
差距分析
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按模式，2021 - 2032 年

主要趨勢
電腦斷層掃描 (CT)
X光
超音波
磁振造影（MRI）
核子醫學

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
心律不整
心臟病發作
心臟衰竭
先天性心臟病
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診斷影像中心
門診手術中心 (ASC)
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Canon Inc.
Carestream Health
CHISON Medical Technologies Co., Ltd.
Esaote SPA
FUJIFILM Holdings Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
Neusoft Corporation
Samsung Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Ziehm Imaging GmbH

簡介目錄

Product Code: 11128

The Global Coronary Heart Disease Diagnostic Imaging Devices Market share recorded USD 1.8 billion in 2022 and will exhibit a growth rate of 6.6% between 2024 and 2032, fueled by the increasing prevalence of coronary heart disease (CHD) and the growing demand for early diagnosis and prevention. As CHD rates rise globally, there is a heightened need for advanced imaging technologies to detect the condition at early stages. Early diagnosis allows for timely intervention, reducing the risk of severe outcomes. This focus on proactive healthcare drives demand for sophisticated diagnostic imaging devices, thereby expanding the market as healthcare systems prioritize effective and early detection solutions.

The overall coronary heart disease diagnostic imaging devices industry is segmented based on modality, application, end-use, and region.

The computed tomography (CT) segment will accumulate USD 443.8 million by 2032 due to its superior imaging capabilities and precision. CT scans provide detailed cross-sectional images of the heart and blood vessels, enabling accurate diagnosis of coronary artery disease and assessment of plaque buildup. The technology's ability to quickly produce high-resolution images makes it a preferred choice for clinicians seeking reliable and efficient diagnostic tools. As demand for detailed cardiac imaging increases, the CT segment will dominate the market.

The heart attack segment captured USD 585.7 million in 2023, attributed to the critical need for rapid and accurate diagnosis in acute scenarios. Timely identification of heart attacks is crucial for effective treatment and improved patient outcomes. Diagnostic imaging devices, such as CT and MRI, play a key role in assessing the extent of heart damage and guiding interventions. As the prevalence of heart attacks continues to rise, the demand for advanced imaging solutions in this segment will drive significant market growth.

The U.S. coronary heart disease diagnostic imaging devices market will reach USD 1.3 billion by 2032, owing to its advanced healthcare infrastructure, high prevalence of coronary heart disease, and substantial investments in medical technology. The country's robust healthcare system and high adoption rates of cutting-edge diagnostic tools, including advanced imaging technologies, drive market growth. Additionally, the U.S. benefits from ongoing research and development efforts, making it a key contributor to the expansion and innovation in the coronary heart disease diagnostic imaging devices industry.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of coronary heart disease
  - 3.2.1.2 Advancements in diagnostic imaging technology
  - 3.2.1.3 Growing awareness and early diagnosis of coronary heart disease
  - 3.2.1.4 Growing demand for non-invasive diagnostic tools
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of imaging devices
  - 3.2.2.2 Lack of skilled professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Gap analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Computed tomography (CT)
5.3 X-ray
5.4 Ultrasound
5.5 Magnetic resonance imaging(MRI)
5.6 Nuclear medicine

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Arrhythmia
6.3 Heart attack
6.4 Heart failure
6.5 Congenital heart conditions
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Diagnostic imaging centers
7.4 Ambulatory surgical centers (ASCs)
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa